speb/financial-data huggingface dataset:
GP cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -884208.00
GP cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -8567.00
GP balance_sheet (annual, 2025-03-31) — Net PPE: 6790137.00
GP balance_sheet (quarterly, 2025-03-31) — Net PPE: 6790137.00
GP cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -83172.00
GP cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3039.00
GP cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -1479634.00
GP cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -89950.00
GP balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -1605966.00
GP balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -1605966.00
GP balance_sheet (annual, 2025-03-31) — Non Current Accounts Receivable: 91455.00
GP balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 91455.00
GP balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 6858820.00
GP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 6858820.00
GP balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 6858820.00
GP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 6858820.00
GP balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 0.00
GP balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 0.00
GP income_statement (annual, 2025-03-31) — Normalized EBITDA: -14865655.00
GP income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2940061.00
GP income_statement (annual, 2025-03-31) — Normalized Income: -18704105.00
GP income_statement (quarterly, 2025-03-31) — Normalized Income: -3835750.00
GP cash_flow (annual, 2025-03-31) — Operating Cash Flow: -5988173.00
GP cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -387809.00
GP cash_flow (annual, 2025-03-31) — Operating Gains Losses: -40657.00
GP cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1836.00
GP income_statement (annual, 2025-03-31) — Operating Income: -17919514.00
GP income_statement (quarterly, 2025-03-31) — Operating Income: -4708744.00
GP income_statement (annual, 2025-03-31) — Operating Revenue: 19847279.00
GP income_statement (quarterly, 2025-03-31) — Operating Revenue: 4284134.00
GP balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 29491162.00
GP balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 29491162.00
GP balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 1334720.00
GP balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1334720.00
GP balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1126326.00
GP balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1126326.00
GP balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 15279279.00
GP balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 15279279.00
GP income_statement (annual, 2025-03-31) — Other Gand A: 3591530.00
GP income_statement (quarterly, 2025-03-31) — Other Gand A: 1320562.00
GP income_statement (annual, 2025-03-31) — Other Income Expense: 1432403.00
GP income_statement (quarterly, 2025-03-31) — Other Income Expense: 1393582.00
GP cash_flow (annual, 2025-03-31) — Other Non Cash Items: -667594.00
GP cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1091103.00
GP balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 415066.00
GP balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 415066.00
GP balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 17133.00
GP balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 17133.00
GP income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1391746.00
GP balance_sheet (annual, 2025-03-31) — Other Properties: 7995182.00
GP balance_sheet (quarterly, 2025-03-31) — Other Properties: 7995182.00
GP balance_sheet (annual, 2025-03-31) — Other Receivables: 45473.00
GP balance_sheet (quarterly, 2025-03-31) — Other Receivables: 45473.00
GP balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 3719716.00
GP balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3719716.00
GP balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1241670.00
GP balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1241670.00
GP income_statement (annual, 2025-03-31) — Pretax Income: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Pretax Income: -3833914.00
GP cash_flow (annual, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
GP cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
GP balance_sheet (annual, 2025-03-31) — Properties: 0.00
GP balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
GP income_statement (annual, 2025-03-31) — Provision For Doubtful Accounts: -12277.00
GP income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: -134295.00
GP cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -12277.00
GP cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -134295.00
GP cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
GP cash_flow (annual, 2025-03-31) — Purchase Of PPE: -83172.00
GP cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3039.00
GP balance_sheet (annual, 2025-03-31) — Raw Materials: 4208596.00
GP balance_sheet (quarterly, 2025-03-31) — Raw Materials: 4208596.00
GP balance_sheet (annual, 2025-03-31) — Receivables: 587266.00
GP balance_sheet (quarterly, 2025-03-31) — Receivables: 587266.00
GP income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 17650661.00
GP income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3823052.00
GP income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1662113.00
GP income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 376937.00
GP cash_flow (annual, 2025-03-31) — Repayment Of Debt: -2042119.00
GP cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 72555.00
GP income_statement (annual, 2025-03-31) — Research And Development: 1339200.00
GP income_statement (quarterly, 2025-03-31) — Research And Development: 329798.00
GP balance_sheet (annual, 2025-03-31) — Restricted Cash: 0.00
GP balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 0.00
GP balance_sheet (annual, 2025-03-31) — Retained Earnings: -97423507.00
GP balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -97423507.00
GP income_statement (annual, 2025-03-31) — Salaries And Wages: 10809963.00
GP income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2718650.00
GP cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
GP income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 997772.00
GP income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 77789.00
GP income_statement (annual, 2025-03-31) — Selling General And Administration: 17127096.00
GP income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4597386.00
GP balance_sheet (annual, 2025-03-31) — Share Issued: 2949116.00
GP balance_sheet (quarterly, 2025-03-31) — Share Issued: 29491162.00
GP cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: -1479634.00
GP cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: -1706705.00
GP cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -1479634.00
GP income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
GP income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
GP cash_flow (annual, 2025-03-31) — Stock Based Compensation: 897468.00
GP cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 63893.00
GP balance_sheet (annual, 2025-03-31) — Stockholders Equity: -1605966.00
GP balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -1605966.00
GP balance_sheet (annual, 2025-03-31) — Tangible Book Value: -1605966.00
GP balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1605966.00
GP income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GP income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GP income_statement (annual, 2025-03-31) — Tax Provision: 0.00
GP income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
GP income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
GP balance_sheet (annual, 2025-03-31) — Total Assets: 35071725.00
GP balance_sheet (quarterly, 2025-03-31) — Total Assets: 35071725.00
GP balance_sheet (annual, 2025-03-31) — Total Capitalization: 1243359.00
GP balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1243359.00
GP balance_sheet (annual, 2025-03-31) — Total Debt: 19927057.00
GP balance_sheet (quarterly, 2025-03-31) — Total Debt: 19927057.00
GP balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -1605966.00
GP balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -1605966.00
GP income_statement (annual, 2025-03-31) — Total Expenses: 37766793.00
GP income_statement (quarterly, 2025-03-31) — Total Expenses: 8992878.00
GP balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 36677691.00
GP balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 36677691.00
GP balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 7296658.00
GP balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7296658.00
GP balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17009432.00
GP balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17009432.00
GP income_statement (annual, 2025-03-31) — Total Operating Income As Reported: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4708744.00
GP income_statement (annual, 2025-03-31) — Total Unusual Items: 40657.00
GP income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1836.00
GP income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 40657.00
GP income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1836.00
GP balance_sheet (annual, 2025-03-31) — Work In Process: 11282556.00
GP balance_sheet (quarterly, 2025-03-31) — Work In Process: 11282556.00
GP balance_sheet (annual, 2025-03-31) — Working Capital: 8106809.00
GP balance_sheet (quarterly, 2025-03-31) — Working Capital: 8106809.00
GP income_statement (quarterly, 2025-06-30) — +Operating Expense: 3946659.00
GP income_statement (quarterly, 2025-06-30) — +Total Revenue: 1549467.00
GP balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 155907.00
GP balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -570619.00
GP income_statement (quarterly, 2025-06-30) — Basic Average Shares: 29642264.00
GP income_statement (quarterly, 2025-06-30) — Basic EPS: -0.14
GP cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 344244.00
GP balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 6082495.00
GP balance_sheet (quarterly, 2025-06-30) — Capital Stock: 80702032.00
GP balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 248184.00
GP balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 248184.00
GP balance_sheet (quarterly, 2025-06-30) — Cash Financial: 248184.00
GP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1278051.00
GP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
GP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1406642.00
GP cash_flow (quarterly, 2025-06-30) — Change In Inventory: 621084.00
GP cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -21325.00
GP cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 810896.00
GP cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 166531.00
GP cash_flow (quarterly, 2025-06-30) — Change In Receivables: 388400.00
GP cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1965586.00
GP cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 378419.00
GP cash_flow (quarterly, 2025-06-30) — Changes In Cash: -128591.00
GP balance_sheet (quarterly, 2025-06-30) — Common Stock: 80702032.00
GP balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -5177234.00
GP cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 197964.00
GP income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1187785.00
GP balance_sheet (quarterly, 2025-06-30) — Current Assets: 26522896.00
GP balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 752115.00
GP balance_sheet (quarterly, 2025-06-30) — Current Debt: 10884512.00
GP balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11636627.00
GP balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3619418.00
GP balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3619418.00
GP balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20567637.00
GP cash_flow (quarterly, 2025-06-30) — Depreciation: 412166.00
GP cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 412166.00
GP income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 412166.00
GP cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 412166.00
GP income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 412166.00
GP income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 412166.00
GP balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 1733242.00
GP income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 29642264.00
GP income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.14
GP income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4163851.00
GP income_statement (quarterly, 2025-06-30) — EBIT: -3591953.00
GP income_statement (quarterly, 2025-06-30) — EBITDA: -3179787.00
GP cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 32531.00
GP cash_flow (quarterly, 2025-06-30) — End Cash Position: 248184.00
GP cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1278051.00
GP balance_sheet (quarterly, 2025-06-30) — Finished Goods: 9888317.00
GP cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1406642.00
GP income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -6976.00
GP balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 15672230.00
GP income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3300814.00
GP balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 726526.00
GP balance_sheet (quarterly, 2025-06-30) — Gross PPE: 6347478.00
GP income_statement (quarterly, 2025-06-30) — Gross Profit: 361682.00
GP income_statement (quarterly, 2025-06-30) — Insurance And Claims: 408495.00
GP income_statement (quarterly, 2025-06-30) — Interest Expense: 571898.00
GP income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 571898.00
GP balance_sheet (quarterly, 2025-06-30) — Inventory: 24980804.00
GP balance_sheet (quarterly, 2025-06-30) — Invested Capital: 9713902.00
GP cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
GP cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 197964.00
GP cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1200000.00
GP balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 9540087.00
GP balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 5330380.00
GP balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 4006624.00
GP balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9337004.00
GP cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1200000.00
GP cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -271472.00
GP cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 197964.00
GP balance_sheet (quarterly, 2025-06-30) — Net Debt: 14642952.00
GP cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 6976.00
GP income_statement (quarterly, 2025-06-30) — Net Income: -4163851.00
GP income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4163851.00
GP income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4163851.00
GP income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4163851.00
GP income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4163851.00
GP cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4163851.00
GP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4163851.00
GP income_statement (quarterly, 2025-06-30) — Net Interest Income: -571898.00
GP cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 916423.00
GP cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 928528.00
GP income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -571898.00
GP cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -36336.00
GP balance_sheet (quarterly, 2025-06-30) — Net PPE: 6347478.00
GP cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
GP cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -12105.00
GP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -5177234.00
GP balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 64085.00
GP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 6858820.00
GP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 6858820.00
GP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3172811.00
GP income_statement (quarterly, 2025-06-30) — Normalized Income: -4156875.00
GP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1406642.00
GP cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 6976.00
GP income_statement (quarterly, 2025-06-30) — Operating Income: -3584977.00
GP income_statement (quarterly, 2025-06-30) — Operating Revenue: 1549467.00
GP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 29552137.00
GP balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1344425.00
GP balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1120862.00
GP balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 15672230.00
GP income_statement (quarterly, 2025-06-30) — Other Gand A: 931906.00
GP income_statement (quarterly, 2025-06-30) — Other Income Expense: -6976.00
GP cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 180870.00
GP balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 400001.00
GP balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 14991.00
GP balance_sheet (quarterly, 2025-06-30) — Other Properties: 6347478.00
GP balance_sheet (quarterly, 2025-06-30) — Other Receivables: 62862.00
GP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4190730.00
GP balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1075139.00
GP income_statement (quarterly, 2025-06-30) — Pretax Income: -4163851.00
GP cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 200000.00
GP income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: 7467.00
GP cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 7467.00
GP cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
GP balance_sheet (quarterly, 2025-06-30) — Raw Materials: 4196664.00
GP balance_sheet (quarterly, 2025-06-30) — Receivables: 218769.00
GP income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1187785.00
GP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 412166.00
GP cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -283577.00
GP income_statement (quarterly, 2025-06-30) — Research And Development: 165951.00
GP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -101551496.00
GP income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1960413.00
GP income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 60261.00
GP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3361075.00
GP balance_sheet (quarterly, 2025-06-30) — Share Issued: 29552137.00
GP cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -12105.00
GP cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 184144.00
GP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -5177234.00
GP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -5177234.00
GP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
GP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
GP balance_sheet (quarterly, 2025-06-30) — Total Assets: 33334460.00
GP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -1170610.00
GP balance_sheet (quarterly, 2025-06-30) — Total Debt: 20973631.00
GP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -5177234.00
GP income_statement (quarterly, 2025-06-30) — Total Expenses: 5134444.00
GP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 38511694.00
GP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 6811564.00
GP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 17944057.00
GP income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3584977.00
GP income_statement (quarterly, 2025-06-30) — Total Unusual Items: -6976.00
GP income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -6976.00
GP balance_sheet (quarterly, 2025-06-30) — Work In Process: 10895823.00
GP balance_sheet (quarterly, 2025-06-30) — Working Capital: 5955259.00
GP income_statement (quarterly, 2025-09-30) — +Operating Expense: 3201298.00
GP income_statement (quarterly, 2025-09-30) — +Total Revenue: 2489820.00
GP balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 740709.00
GP balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -595681.00
GP income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3034763.00
GP income_statement (quarterly, 2025-09-30) — Basic EPS: -1.18
GP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 248184.00
GP balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 5925329.00
GP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 81004970.00
GP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 511094.00
GP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 511094.00
GP balance_sheet (quarterly, 2025-09-30) — Cash Financial: 511094.00
GP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 80349.00
GP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 15065.00
GP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 171296.00
GP cash_flow (quarterly, 2025-09-30) — Change In Inventory: 1011891.00
GP cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -185679.00
GP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1679813.00
GP cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 563616.00
GP cash_flow (quarterly, 2025-09-30) — Change In Receivables: -597686.00
GP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2290061.00
GP cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -609863.00
GP cash_flow (quarterly, 2025-09-30) — Changes In Cash: 266710.00
GP balance_sheet (quarterly, 2025-09-30) — Common Stock: 81004970.00
GP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -8334120.00
GP cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 382131.00
GP income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2216102.00
GP balance_sheet (quarterly, 2025-09-30) — Current Assets: 25588800.00
GP balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 766559.00
GP balance_sheet (quarterly, 2025-09-30) — Current Debt: 7941753.00
GP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 8708312.00
GP balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 5770245.00
GP balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 5770245.00
GP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 19236491.00
GP cash_flow (quarterly, 2025-09-30) — Depreciation: 350080.00
GP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 350080.00
GP income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 350080.00
GP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 350080.00
GP income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 350080.00
GP income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 350080.00
GP balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 1748313.00
GP income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3034763.00
GP income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.18
GP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3593359.00
GP income_statement (quarterly, 2025-09-30) — EBIT: -2980999.00
GP income_statement (quarterly, 2025-09-30) — EBITDA: -2630919.00
GP cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -3800.00
GP cash_flow (quarterly, 2025-09-30) — End Cash Position: 511094.00
GP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 80349.00
GP balance_sheet (quarterly, 2025-09-30) — Finished Goods: 9714132.00
GP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 171296.00
GP income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -24961.00
GP income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -28458.00
GP balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 15784100.00
GP income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2602113.00
GP balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1336390.00
GP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5970716.00
GP income_statement (quarterly, 2025-09-30) — Gross Profit: 273718.00
GP income_statement (quarterly, 2025-09-30) — Insurance And Claims: 384041.00
GP income_statement (quarterly, 2025-09-30) — Interest Expense: 612360.00
GP income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 612360.00
GP balance_sheet (quarterly, 2025-09-30) — Inventory: 23758913.00
GP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6936975.00
GP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 15065.00
GP cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 382131.00
GP cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 200000.00
GP balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 7841753.00
GP balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5158770.00
GP balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 7329342.00
GP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 12488112.00
GP cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 200000.00
GP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -461836.00
GP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 382131.00
GP balance_sheet (quarterly, 2025-09-30) — Net Debt: 14760001.00
GP cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 28458.00
GP income_statement (quarterly, 2025-09-30) — Net Income: -3593359.00
GP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3593359.00
GP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3593359.00
GP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3593359.00
GP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3593359.00
GP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3593359.00
GP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3593359.00
GP income_statement (quarterly, 2025-09-30) — Net Interest Income: -612360.00
GP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -249731.00
GP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -261836.00
GP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -612360.00
GP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -77051.00
GP balance_sheet (quarterly, 2025-09-30) — Net PPE: 5970716.00
GP cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
GP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -8334120.00
GP balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 48209.00
GP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 6858820.00
GP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 6858820.00
GP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2577500.00
GP income_statement (quarterly, 2025-09-30) — Normalized Income: -3539940.00
GP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 171296.00
GP cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 53419.00
GP income_statement (quarterly, 2025-09-30) — Operating Income: -2927580.00
GP income_statement (quarterly, 2025-09-30) — Operating Revenue: 2489820.00
GP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3077483.00
GP balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 100000.00
GP balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 920112.00
GP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 15784100.00
GP income_statement (quarterly, 2025-09-30) — Other Gand A: 893895.00
GP income_statement (quarterly, 2025-09-30) — Other Income Expense: -53419.00
GP cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 750332.00
GP balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 402741.00
GP balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 12850.00
GP balance_sheet (quarterly, 2025-09-30) — Other Properties: 5970716.00
GP balance_sheet (quarterly, 2025-09-30) — Other Receivables: 66561.00
GP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3837822.00
GP balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 511523.00
GP income_statement (quarterly, 2025-09-30) — Pretax Income: -3593359.00
GP cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 25000.00
GP income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 25061.00
GP cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 25062.00
GP cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
GP balance_sheet (quarterly, 2025-09-30) — Raw Materials: 4324176.00
GP balance_sheet (quarterly, 2025-09-30) — Receivables: 807270.00
GP income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2216102.00
GP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 350080.00
GP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -449731.00
GP income_statement (quarterly, 2025-09-30) — Research And Development: 221104.00
GP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -105123190.00
GP income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1324177.00
GP income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2940.00
GP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2605053.00
GP balance_sheet (quarterly, 2025-09-30) — Share Issued: 3077483.00
GP income_statement (quarterly, 2025-09-30) — Special Income Charges: -24961.00
GP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 85701.00
GP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -8334120.00
GP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -8334120.00
GP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
GP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
GP balance_sheet (quarterly, 2025-09-30) — Total Assets: 32010466.00
GP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -1004778.00
GP balance_sheet (quarterly, 2025-09-30) — Total Debt: 21196424.00
GP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -8334120.00
GP income_statement (quarterly, 2025-09-30) — Total Expenses: 5417400.00
GP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 40344586.00
GP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 6421666.00
GP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 21108095.00
GP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2927580.00
GP income_statement (quarterly, 2025-09-30) — Total Unusual Items: -53419.00
GP income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -53419.00
GP balance_sheet (quarterly, 2025-09-30) — Work In Process: 9720605.00
GP balance_sheet (quarterly, 2025-09-30) — Working Capital: 6352309.00
GP income_statement (quarterly, 2025-12-31) — +Operating Expense: 2393601.00
GP income_statement (quarterly, 2025-12-31) — +Total Revenue: 8495323.00
GP balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 71873.00
GP balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -346445.00
GP cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 90000.00
GP income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3192199.00
GP income_statement (quarterly, 2025-12-31) — Basic EPS: 1.32
GP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 511094.00
GP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5725207.00
GP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 81956378.00
GP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 675950.00
GP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 675950.00
GP balance_sheet (quarterly, 2025-12-31) — Cash Financial: 675950.00
GP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1418728.00
GP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
GP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1212326.00
GP cash_flow (quarterly, 2025-12-31) — Change In Inventory: 22648.00
GP cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 24421.00
GP cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -7456878.00
GP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 50154.00
GP cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 283117.00
GP cash_flow (quarterly, 2025-12-31) — Change In Receivables: 716934.00
GP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -6359604.00
GP cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 705839.00
GP cash_flow (quarterly, 2025-12-31) — Changes In Cash: 206402.00
GP balance_sheet (quarterly, 2025-12-31) — Common Stock: 81956378.00
GP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -3158207.00
GP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
GP income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1176572.00
GP balance_sheet (quarterly, 2025-12-31) — Current Assets: 24685173.00
GP balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 788741.00
GP balance_sheet (quarterly, 2025-12-31) — Current Debt: 7956720.00
GP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8745461.00
GP balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 5172187.00
GP balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 5172187.00
GP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 18922997.00
GP cash_flow (quarterly, 2025-12-31) — Depreciation: 339259.00
GP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 339259.00
GP income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 339219.00
GP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 339259.00
GP income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 339219.00
GP income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 339219.00
GP balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 1770180.00
GP income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3192199.00
GP income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.32
GP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 4213685.00
GP income_statement (quarterly, 2025-12-31) — EBIT: 4924168.00
GP income_statement (quarterly, 2025-12-31) — EBITDA: 5263427.00
GP cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -41546.00
GP cash_flow (quarterly, 2025-12-31) — End Cash Position: 675950.00
GP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1418728.00
GP balance_sheet (quarterly, 2025-12-31) — Finished Goods: 9099267.00
GP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1212326.00
GP cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
GP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
GP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -982.00
GP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 15789875.00
GP income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1929235.00
GP balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 418318.00
GP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 5632570.00
GP income_statement (quarterly, 2025-12-31) — Gross Profit: 7318751.00
GP income_statement (quarterly, 2025-12-31) — Insurance And Claims: 302682.00
GP income_statement (quarterly, 2025-12-31) — Interest Expense: 710483.00
GP income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 710483.00
GP balance_sheet (quarterly, 2025-12-31) — Inventory: 23646265.00
GP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 13080369.00
GP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
GP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1120050.00
GP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 513457.00
GP balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 7856720.00
GP balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4936466.00
GP balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 8281856.00
GP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13218322.00
GP cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 513457.00
GP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -46137.00
GP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
GP balance_sheet (quarterly, 2025-12-31) — Net Debt: 15562626.00
GP cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 418.00
GP income_statement (quarterly, 2025-12-31) — Net Income: 4213685.00
GP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 4213685.00
GP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 4213685.00
GP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4213685.00
GP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4213685.00
GP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 4213685.00
GP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 4213685.00
GP income_statement (quarterly, 2025-12-31) — Net Interest Income: -710483.00
GP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 467320.00
GP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 467320.00
GP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -710483.00
GP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -168642.00
GP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
GP balance_sheet (quarterly, 2025-12-31) — Net PPE: 5632570.00
GP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
GP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -3158207.00
GP balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 40996.00
GP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
GP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 0.00
GP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 5264409.00
GP income_statement (quarterly, 2025-12-31) — Normalized Income: 4214460.78
GP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1212326.00
GP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 418.00
GP income_statement (quarterly, 2025-12-31) — Operating Income: 4925150.00
GP income_statement (quarterly, 2025-12-31) — Operating Revenue: 8495323.00
GP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 3367227.00
GP balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 100000.00
GP balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 929090.00
GP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 15789875.00
GP income_statement (quarterly, 2025-12-31) — Other Gand A: 500314.00
GP income_statement (quarterly, 2025-12-31) — Other Income Expense: -982.00
GP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 490046.00
GP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 405261.00
GP balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 10708.00
GP balance_sheet (quarterly, 2025-12-31) — Other Properties: 5632570.00
GP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 62679.00
GP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4076259.00
GP balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 228406.00
GP income_statement (quarterly, 2025-12-31) — Pretax Income: 4213685.00
GP cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
GP income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: -37004.00
GP cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -37005.00
GP cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
GP balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4220323.00
GP balance_sheet (quarterly, 2025-12-31) — Receivables: 134552.00
GP income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1176532.00
GP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 339259.00
GP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -46137.00
GP income_statement (quarterly, 2025-12-31) — Research And Development: 151381.00
GP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -100904460.00
GP income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1126239.00
GP income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 10770.00
GP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1940005.00
GP balance_sheet (quarterly, 2025-12-31) — Share Issued: 3367227.00
GP income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
GP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 50875.00
GP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -3158207.00
GP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -3158207.00
GP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -206.22
GP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
GP balance_sheet (quarterly, 2025-12-31) — Total Assets: 30764000.00
GP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 5123649.00
GP balance_sheet (quarterly, 2025-12-31) — Total Debt: 21963783.00
GP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -3158207.00
GP income_statement (quarterly, 2025-12-31) — Total Expenses: 3570173.00
GP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 33922207.00
GP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 6078827.00
GP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 14999210.00
GP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 4925150.00
GP income_statement (quarterly, 2025-12-31) — Total Unusual Items: -982.00
GP income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -982.00
GP balance_sheet (quarterly, 2025-12-31) — Work In Process: 10326675.00
GP balance_sheet (quarterly, 2025-12-31) — Working Capital: 5762176.00
GP income_statement (annual, 2026-03-31) — +Operating Expense: 10738250.00
GP income_statement (quarterly, 2026-03-31) — +Operating Expense: 1196692.00
GP income_statement (annual, 2026-03-31) — +Total Revenue: 16388579.00
GP income_statement (quarterly, 2026-03-31) — +Total Revenue: 3853969.00
GP balance_sheet (annual, 2026-03-31) — Accounts Receivable: 331822.00
GP balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 331822.00
GP balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -5632698.00
GP balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -5632698.00
GP balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -256788.00
GP balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -256788.00
GP cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 988190.00
GP cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 688190.00
GP income_statement (annual, 2026-03-31) — Basic Average Shares: 3494860.00
GP income_statement (annual, 2026-03-31) — Basic EPS: -1.57
GP cash_flow (annual, 2026-03-31) — Beginning Cash Position: 344244.00
GP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 675950.00
GP balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 5552263.00
GP balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5552263.00
GP balance_sheet (annual, 2026-03-31) — Capital Stock: 86544102.00
GP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 86544102.00
GP balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 328086.00
GP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 328086.00
GP balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 328086.00
GP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 328086.00
GP balance_sheet (annual, 2026-03-31) — Cash Financial: 328086.00
GP balance_sheet (quarterly, 2026-03-31) — Cash Financial: 328086.00
GP cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: 6105494.00
GP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 3328366.00
GP cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: 11950.00
GP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3115.00
GP cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: -6184341.00
GP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -3736669.00
GP cash_flow (annual, 2026-03-31) — Change In Account Payable: -302613.00
GP cash_flow (annual, 2026-03-31) — Change In Inventory: 654925.00
GP cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1000698.00
GP cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -221576.00
GP cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -38993.00
GP cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -7562306.00
GP cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -2596137.00
GP cash_flow (annual, 2026-03-31) — Change In Payable: -302613.00
GP cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: -302613.00